Allograft Cellular Bone Matrix in Extreme Lateral Interbody Fusion: Preliminary Radiographic and Clinical Outcomes
Introduction. Extreme lateral interbody fusion (XLIF) is a minimally disruptive alternative for anterior lumbar interbody fusion. Recently, synthetic and allograft materials have been increasingly used to eliminate donor-site pain and complications secondary to autogenous bone graft harvesting. The...
Saved in:
Main Authors: | Antoine G. Tohmeh, Blake Watson, Mirna Tohmeh, Xavier J. Zielinski |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2012/263637 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Outcome and Fusion Rates after the First 30 Extreme Lateral Interbody Fusions
by: Gregory M. Malham, et al.
Published: (2012-01-01) -
Clinical Outcomes of Extreme Lateral Interbody Fusion in the Treatment of Adult Degenerative Scoliosis
by: Adam M. Caputo, et al.
Published: (2012-01-01) -
Stand-Alone Lateral Interbody Fusion for the Treatment of Low-Grade Degenerative Spondylolisthesis
by: Luis Marchi, et al.
Published: (2012-01-01) -
Miniopen Oblique Lateral L5-S1 Interbody Fusion: A Report of 2 Cases
by: Keijiro Kanno, et al.
Published: (2014-01-01) -
Safety and Efficacy of Polyetheretherketone (PEEK) Cages and Cadaveric Allografts in Transforaminal Lumbar Interbody Fusion (TLIF) for Treating Lumbar Pyogenic Spondylodiscitis
by: Huo-Liang Zheng, et al.
Published: (2023-01-01)